Gwen ifil's death spotlights endometrial cancer

feature-image

Play all audios:

Loading...

The death of renowned PBS newscaster Gwen Ifill at age 61 has cast new attention on endometrial cancer, the most common cancer of the female reproductive system and one that strikes


postmenopausal women almost exclusively. Ifill was the longtime coanchor of _The PBS NewsHour_ and moderator of PBS’ _Washington Week_ roundtable public affairs show. Most recently, she was


a moderator of a Democratic primary debate between former secretary of state Hillary Clinton and Sen. Bernie Sanders. President Obama called her a friend and an extraordinary journalist.


_“_I always appreciated Gwen’s reporting, even when I was at the receiving end of her tough and thorough interviews,” he said in a news conference. Ifill died Nov. 14 at a hospice center in


Washington, D.C. Her family said the cause was endometrial cancer, according to the _Washington Post_. Also called uterine cancer, endometrial cancer begins with abnormal cell growth in the


inner lining of the uterus. Annually, about 60,000 women will be diagnosed with it and more than 10,000 will die from it. And while the overall rate of cancer in the U.S. has been declining


over the past 20 years, the incidence of endometrial cancer is increasing, particularly the aggressive kind, according to a 2015 study. The average age of women diagnosed with endometrial


cancer is 60 — it is rare in women under age 45 — and while it’s slightly more common in white women, African American women are more likely to have an aggressive form of the disease and to


die from it. There is also no screening test to detect the disease, so while it’s highly treatable if caught early, the American Cancer Society says it’s important that at menopause, all


women should be told about the risks and symptoms of endometrial cancer and to report any vaginal bleeding, discharge or spotting to their doctor. Here is what you need to know: RECOGNIZE


THE SIGNS AND SYMPTOMS. Unusual vaginal bleeding, spotting or other discharge is the most common warning sign. About 90 percent of women with endometrial cancer had these symptoms. See your


doctor for any irregular bleeding or pain in the pelvis right away. DON’T RELY ON YOUR REGULAR PELVIC EXAM OR PAP TEST. They’re ineffective at detecting early endometrial cancer, says the


cancer society. (The Pap test screens for cervical cancer, not endometrial.) KNOW YOUR RISK FACTORS. They include being older than 50; obesity (the disease is three times as common in obese


women); diabetes (four times as common in women with diabetes); taking estrogen (without progesterone) during menopause; taking tamoxifen, a drug used to treat some forms of breast cancer; a


family history of uterine or ovarian cancer; and a family history of an inherited type of colon cancer called hereditary nonpolyposis colon cancer (HNPCC), which can raise the risk of


endometrial cancer by 40 to 60 percent.